Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
View ORCID ProfileI Van Walle, K Leitmeyer, View ORCID ProfileE K Broberg on behalf of the European COVID-19 microbiological laboratories group
doi: https://doi.org/10.1101/2020.09.16.20195917
I Van Walle
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
K Leitmeyer
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
E K Broberg
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
1European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

Data Availability
All data are either publicly available or included in the supplementary material
Posted September 18, 2020.
Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
I Van Walle, K Leitmeyer, E K Broberg
medRxiv 2020.09.16.20195917; doi: https://doi.org/10.1101/2020.09.16.20195917
Subject Area
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (731)
- Anesthesia (215)
- Cardiovascular Medicine (3136)
- Dermatology (266)
- Emergency Medicine (465)
- Epidemiology (13096)
- Forensic Medicine (14)
- Gastroenterology (872)
- Genetic and Genomic Medicine (4912)
- Geriatric Medicine (451)
- Health Economics (757)
- Health Informatics (3098)
- Health Policy (1110)
- Hematology (411)
- HIV/AIDS (976)
- Medical Education (458)
- Medical Ethics (121)
- Nephrology (506)
- Neurology (4678)
- Nursing (248)
- Nutrition (692)
- Oncology (2409)
- Ophthalmology (687)
- Orthopedics (270)
- Otolaryngology (333)
- Pain Medicine (312)
- Palliative Medicine (88)
- Pathology (522)
- Pediatrics (1252)
- Primary Care Research (526)
- Public and Global Health (7238)
- Radiology and Imaging (1616)
- Respiratory Medicine (946)
- Rheumatology (463)
- Sports Medicine (406)
- Surgery (521)
- Toxicology (65)
- Transplantation (223)
- Urology (193)